KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Gains from Investment Securities (2016 - 2026)

Jazz Pharmaceuticals has reported Gains from Investment Securities over the past 16 years, most recently at $139.8 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 128.63% year-over-year to $139.8 million; the TTM value through Dec 2025 reached $121.8 million, up 6.01%, while the annual FY2025 figure was $121.8 million, 6.01% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $139.8 million at Jazz Pharmaceuticals, up from -$87.4 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $139.8 million in Q4 2025 and troughed at -$101.7 million in Q3 2023.
  • A 5-year average of $17.4 million and a median of $7.9 million in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 4809.7% in 2021 and later crashed 641.75% in 2023.
  • Year by year, Gains from Investment Securities stood at $45.2 million in 2021, then plummeted by 105.12% to -$2.3 million in 2022, then skyrocketed by 4646.85% to $105.2 million in 2023, then tumbled by 41.87% to $61.2 million in 2024, then soared by 128.63% to $139.8 million in 2025.
  • Business Quant data shows Gains from Investment Securities for JAZZ at $139.8 million in Q4 2025, -$87.4 million in Q3 2025, and $68.7 million in Q2 2025.